πŸ‡ΊπŸ‡Έ FDA
Patent

US 8722716

Isoxazole treatments for diabetes

granted A61KA61K31/415A61K31/42

Quick answer

US patent 8722716 (Isoxazole treatments for diabetes) held by The Board of Regents of the University of Texas System expires Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 13 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/415, A61K31/42, A61K31/422, A61P